Previous study reports that ALKBH5 of peripheral blood immune cells is a prospective biomarker for the diagnosis of non-small cell lung cancer [73]and targeting ALKBH5 may be a promising therapeutic method for gastric cancer patients [74]. This evidence concerns the gene ALKBH5 and gastric cancer.